In vivo evidence for the existence of autoreceptors on dopaminergic, serotonergic, and cholinergic neurons in the brain
- PMID: 1977359
- DOI: 10.1111/j.1749-6632.1990.tb32015.x
In vivo evidence for the existence of autoreceptors on dopaminergic, serotonergic, and cholinergic neurons in the brain
Abstract
Intrastriatal infusions as well as systemic administration of the selective D-2 antagonist (-)-sulpiride caused similar increases in the dialysate levels of dopamine (DA) to about 180% of controls. A similar conclusion was drawn when the selective D-2 agonist (-)-N-0437 was infused intrastriatally or administered systemically: both routes of administration caused a decrease in the release of DA to about 40-50% of controls. In order to evaluate the properties of synthesis-modulating autoreceptors on dopaminergic and serotonergic neurons we have estimated the synthesis rate of serotonin (5-HT) or DA by monitoring the 5-HTP or DOPA formation in the dialysates during infusion of a decarboxylase inhibitor. Infusion of (-)-N-0437 decreased the DOPA formation, whereas infusion of (-)-sulpiride increased the dialysate levels of DOPA; these results indicate that the D-2 receptors controlling the synthesis of DA are localized on nerve terminals. Administration of the selective 5-HT-IA agonist 8-hydroxy-dipropyl-aminotetraline (8-OH-DPAT) resulted in a decrease in the synthesis rate of 5-HT. When 8-OH-DPAT was infused via the dialysis membrane, the agonist was unable to modify the release of 5-HT. The effects of infusion of the muscarinic agonist oxotremorine and the muscarinic antagonist atropine were dependent on the presence of the esterase inhibitor neostigmine in the perfusion fluid. In the absence of neostigmine, oxotremorine caused a pronounced decrease in the output of acetylcholine (ACh), whereas atropine was without effect. In the presence of neostigmine oxotremorine was without effect but infusion of atropine or other anticholinergics caused a pronounced increase in the dialysate levels of ACh. It is concluded that the autoreceptor controlling the release of ACh is of the M3-type and that the receptor is not fully occupied during normal conditions. In conclusion, microdialysis of neurotransmitters is a valuable tool for the study of autoreceptors in vivo. The presented studies provided evidence for the existence of autoreceptors controlling the synthesis and/or release of DA, 5-HT, as well as ACh in the striatum.
Similar articles
-
Dopaminergic-cholinergic interactions in the striatum: the critical significance of calcium concentrations in brain microdialysis.Naunyn Schmiedebergs Arch Pharmacol. 1990 Nov;342(5):528-34. doi: 10.1007/BF00169041. Naunyn Schmiedebergs Arch Pharmacol. 1990. PMID: 2090951
-
Characterization and pharmacological responsiveness of dopamine release recorded by microdialysis in the substantia nigra of conscious rats.J Neurochem. 1991 Sep;57(3):738-47. doi: 10.1111/j.1471-4159.1991.tb08214.x. J Neurochem. 1991. PMID: 1677674
-
Effect of quinine on autoreceptor-regulated dopamine release in the rat striatum.J Neurochem. 1992 Nov;59(5):1640-5. doi: 10.1111/j.1471-4159.1992.tb10993.x. J Neurochem. 1992. PMID: 1357098
-
The roles of dopamine and serotonin, and of their receptors, in regulating sleep and waking.Prog Brain Res. 2008;172:625-46. doi: 10.1016/S0079-6123(08)00929-1. Prog Brain Res. 2008. PMID: 18772053 Review.
-
Differential decrease in the rate of dopamine synthesis in several dopaminergic neurons of aged rat brain.Exp Gerontol. 1987;22(1):17-25. doi: 10.1016/0531-5565(87)90011-8. Exp Gerontol. 1987. PMID: 3297754 Review.
Cited by
-
Clozapine-induced dopamine release in the medial prefrontal cortex is augmented by a moderate concentration of locally administered tyrosine but attenuated by high tyrosine concentrations or by tyrosine depletion.Psychopharmacology (Berl). 2005 Jun;179(4):713-24. doi: 10.1007/s00213-004-2091-4. Epub 2005 Jan 29. Psychopharmacology (Berl). 2005. PMID: 15682305
-
Towards a reconceptualization of striatal interactions between glutamatergic and dopaminergic neurotransmission and their contribution to the production of movements.Curr Neuropharmacol. 2009 Jun;7(2):132-41. doi: 10.2174/157015909788848893. Curr Neuropharmacol. 2009. PMID: 19949572 Free PMC article.
-
D2-Like dopamine autoreceptor activation reduces quantal size in PC12 cells.J Neurosci. 1998 Aug 1;18(15):5575-85. doi: 10.1523/JNEUROSCI.18-15-05575.1998. J Neurosci. 1998. PMID: 9671649 Free PMC article.
-
Dopaminergic regulation of sleep and cataplexy in a murine model of narcolepsy.Sleep. 2010 Oct;33(10):1295-304. doi: 10.1093/sleep/33.10.1295. Sleep. 2010. PMID: 21061851 Free PMC article.
-
In vivo microdialysis of noradrenaline overflow: effects of alpha-adrenoceptor agonists and antagonists measured by cumulative concentration-response curves.Br J Pharmacol. 1993 Jul;109(3):655-60. doi: 10.1111/j.1476-5381.1993.tb13623.x. Br J Pharmacol. 1993. PMID: 8102934 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources